Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Imipenem Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/22/2020 Oct/29/2020 0
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/15/2020 Oct/16/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Sep/14/2020 Oct/27/2020 0
Tegobuvir Potential treatment - theoretical effect Experimental Antiviral Aug/24/2020 Sep/18/2020 0
Conivaptan HCl Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/24/2020 Sep/18/2020 0
Entecavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/23/2020 Oct/29/2020 0
Qingdainone Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020 Oct/29/2020 0
Edgeworoside C Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020 Oct/29/2020 0
Adlumidine Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020 Oct/29/2020 0
Ararobinol Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020 Oct/29/2020 0